Skip to content

Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth

Small Intestinal Bacterial Overgrowth

The objective of the study is to assess feasibility, and clinical efficacy of a novel Fecal Microbiota Transplantation protocol for the treatment of pediatric small intestinal bacterial overgrowth (SIBO).

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    3 to 18

Critères de participation

Inclusion Criteria:

* Patients 3-18 years old
* Patients will discontinue antibiotics for at least 1 week prior to FMT
* A diagnosis of SIBO established through lactose breath test (LBT), and showing of symptoms of SIBO

Exclusion Criteria:

* Participants will not be permitted to start any new treatments (including antibiotics, probiotics, antacid treatments, or antimotility treatments) until Week 8, unless clinically indicated
* We will exclude participants \<3yo to avoid potential concerns of microbial transmission in young children, and to ensure participants are developmentally able to perform LBT

Lieu de l'étude

McMaster Children's Hospital
McMaster Children's Hospital
Hamilton, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Nikhil Pai, MD

[email protected]
905-521-2100
Backup Contact

Fariha Chowdhury, BASc, MSc, PhD(c)

Étude parrainée par
McMaster Children's Hospital
Participants recherchés
Plus d'informations
ID de l'étude: NCT05967871